GANX

NASDAQ · Equity

Gain Therapeutics Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
1.950000
Fair value
2.489099
Expectation
Negative 42.43%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
1.95
12-Week Change
-19.75%
Trend Signal
Inactive
Expectation
Negative 42.43%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-24.47
Market Dynamics
-0.39

Over the latest 12 completed weeks ending 2026-05-29, GANX fell 19.75%, moving from 2.43 to 1.95. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -24.47 and has softened across the 12-week window. Market Dynamics is -0.39 on the latest week. Expectation is negative at 42.43%.